The Challenge of Drug-Resistant Epilepsy Epilepsy is considered drug-resistant when a patient fails to achieve seizure control after trying two or more appropriately chosen and tolerated anti-seizure medications. This refractory condition affects roughly 30% of people with epilepsy.

Surgical Interventions For patients whose seizures originate from a well-defined area of the brain, surgery to remove or ablate the affected tissue is a primary option.

• Open Resection: Traditional open surgery to remove the seizure focus (such as in mesial temporal sclerosis) offers a high rate of seizure freedom but carries risks of permanent neurological deficits.
• Laser Interstitial Thermal Therapy (LITT): A minimally invasive alternative that utilizes MRI-guided thermal energy (a laser) to precisely ablate the epileptogenic tissue, offering a shorter recovery time and superior safety profile compared to open surgery.

Neuromodulation Devices When surgical resection is not possible (e.g., if seizures originate from eloquent cortex or multiple areas), doctors turn to implantable neurostimulation devices.

• Responsive Neurostimulation (RNS): A "closed-loop" pacemaker-like device implanted in the skull that continuously monitors brain activity through electrocorticography. When it detects specific epileptiform patterns, it delivers targeted electrical stimulation to disrupt the seizure before it spreads. RNS has demonstrated a 75% median reduction in seizure frequency over 9 years of use.
• Vagus Nerve Stimulation (VNS): An FDA-approved device implanted under the skin of the chest that sends regular, mild electrical pulses to the vagus nerve in the neck. These signals travel to the brainstem to modulate cortical excitability and disrupt abnormal synchrony, reducing seizure frequency by at least 50% in roughly half of patients over two to four years.
• Deep Brain Stimulation (DBS): Involves implanting electrodes deep into specific brain regions, such as the thalamus, which are connected to a pulse generator to deliver electrical impulses and reduce seizure tendency.

Metabolic and Dietary Therapies The Ketogenic Diet—a high-fat, extremely low-carbohydrate diet—forces the brain to shift from using glucose to using ketone bodies for energy. This metabolic switch has been shown to stabilize overactive neurons, reduce the release of excitatory neurotransmitters, enhance inhibitory GABAergic activity, and improve mitochondrial function, offering significant seizure reduction for many patients.

Emerging AI and Seizure Forecasting Moving toward proactive care, researchers are utilizing wearable sensors (tracking heart rate, movement, etc.) and artificial intelligence algorithms to forecast seizures. By analyzing multiday biological rhythms and digital biomarkers, these tools aim to identify windows of high seizure risk, allowing patients and doctors to adjust treatments dynamically or take safety precautions before a seizure strikes.